2025 annual financial data
bioAffinity Technologies 2025 Operating margin
Direct answer
Operating margin was -171.58%.
Operating income was -10,572,508 USD and net income was -14,909,754 USD.
Operating cash flow was -9,328,842 USD.
Get free bioAffinity Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,161,959 USD
- Operating income
- -10,572,508 USD
- Net income
- -14,909,754 USD
- Operating cash flow
- -9,328,842 USD